Injective (INJ) is currently trading at $5.43, reflecting a 4.07% increase over the past 24 hours. The daily price range has been relatively stable, with a high of $5.51 and a low of $5.06, indicating a consolidated market environment.

Volume has reached 53,253,088, translating to a Vol/Market Cap ratio of 9.81%. This suggests active trading and a healthy interest in INJ, supporting the current upward price movement.

From a technical perspective, the hourly moving averages show a bullish trend, with the 8 SMA at $5.33 indicating a 1.80% gain and the 13 SMA at $5.27 reflecting a 3.06% increase. The 21 SMA at $5.23 and the 55 SMA at $5.26 also indicate positive momentum, while the 144 SMA shows a more moderate increase of 2.48%.

The 1-hour RSI is notably high at 86, suggesting that INJ is overbought in the short term. However, the 7-day RSI stands at 52, indicating that the asset is relatively neutral over a longer timeframe, with the 7-day price change at 5.09%, the 14-day change at 11.32%, and the 30-day change at 17.61%.

With the all-time high at $52.62, the current price of $5.43 represents a significant discount, indicating potential for long-term growth. The current market dynamics and technical indicators point towards continued upward momentum, supported by a robust volume profile.

Based on the analysis of price action, RSI levels, and moving averages, I recommend a Buy rating for Injective (INJ). The combination of bullish technical signals, a healthy volume, and a favorable price history suggests that INJ is positioned for further appreciation in the near term.